712270-39-8

Basic information

• Product Name: 3-Piperidinecarboxylic acid, 1-acetyl-, (3R)- (9CI)
• Synonyms: (3R)-1-acetylpiperidine-3-carboxylic acid;3-Piperidinecarboxylic acid, 1-acetyl-, (3R)- (9CI);N-Ac-R-3-Piperidinecarboxylic acid
• CAS NO: 712270-39-8
• Molecular Formula: C8H13NO3
• Molecular Weight: 171.19372
• Product Categories: ACETYLGROUP
• Mol File: 712270-39-8.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 374.0±35.0 °C(Predicted)
• Appearance: /
• Density: 1.213±0.06 g/cm3(Predicted)
• PKA: 4.25±0.20(Predicted)
• CAS DataBase Reference: 3-Piperidinecarboxylic acid, 1-acetyl-, (3R)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Piperidinecarboxylic acid, 1-acetyl-, (3R)- (9CI)(712270-39-8)
• EPA Substance Registry System: 3-Piperidinecarboxylic acid, 1-acetyl-, (3R)- (9CI)(712270-39-8)

Safety Data

• Hazardous Substances Data: 712270-39-8(Hazardous Substances Data)

Upstream product

• 498-95-3 nipecotic acid 

Relevant articles and documents

BETA-LACTAMASE INHIBITORS AND THEIR PREPARATION

Provided herein are novel β-lactamase inhibitors, for the treatment of bacterial infections in combination with β-lactam antibiotics, including infection caused by drug resistant organisms and especially multi-drug resistant organisms. It includes compounds according to formula (I): or pharmaceutically acceptable salts thereof, wherein M and R are as defined herein.

Tricyclic compounds

Novel compounds of Formula STR1 are disclosed. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering a compound of the formula to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being.

Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases

Novel compounds of Formula (7.0a), (7.0b) or (7.0c): STR1 are disclosed. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering a compound of the formula (7.0a), (7.0b) or (7.0c) to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being.